Application 018012
- Type
- NDA
- Sponsor
- SPECGX LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PAMELOR | NORTRIPTYLINE HYDROCHLORIDE | SOLUTION;ORAL | EQ 10MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018012-001 | PAMELOR | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N018012-001 | PAMELOR | EQ 10MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 51778813-0ec1-6b4f-e054-00144ff8d46c | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 8a294b63-7268-4105-8e17-a59ef889d572 | 2024-07-11 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | 1a904ddf-574a-8a24-e063-6394a90aba3b | 2024-06-07 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | dbe85bdc-17a1-4201-bf48-a52e35d69b68 | 2024-03-27 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 4442f029-dd5e-4834-9b01-eb8c638ce4b1 | 2024-02-21 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 8811104b-6223-4ea6-a9c6-61d63a21b3cd | 2024-02-21 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 53346b9c-40a1-4b5b-8df0-0b393661fb85 | 2024-02-12 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | f1868790-c70b-4979-974d-3ce0ffe99e36 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | DIRECT RX | 45884cad-4a2d-44f4-93bd-16b130daf32d | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Dr. Reddy's Laboratories Inc. | b1d9582c-742c-91a8-c2b3-bbdb21220470 | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 30263e15-de21-4db4-aceb-59d619909e82 | 2023-03-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 70921f99-1f25-4a8c-8269-6d5d26be7a63 | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 59a65e6f-b812-4195-b85b-c412fb902c93 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | c5b1ef5e-9681-426a-abf6-60d9c28d92a0 | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Mayne Pharma Inc. | 765d726b-fd4b-4ef7-afd7-9e7e9bf8cae6 | 2021-03-24 | Boxed warning, Warnings, Adverse reactions | NORTRIPTYLINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 33391 | SUPPL | 2014-07-29 |
| 13976 | SUPPL | 2014-07-29 |
| 11112 | SUPPL | 2014-07-11 |
| 777 | SUPPL | 2014-07-11 |
| 776 | SUPPL | 2012-10-29 |
| 11111 | SUPPL | 2012-10-26 |
| 43603 | ORIG | 2009-11-20 |
| 40770 | SUPPL | 2009-09-14 |
| 775 | SUPPL | 2007-07-24 |
| 33390 | SUPPL | 2007-07-16 |
| 44016 | ORIG | 2007-05-09 |
| 11110 | SUPPL | 2005-01-13 |
| 774 | SUPPL | 2005-01-13 |
| 33389 | SUPPL | 2003-04-11 |